JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
+$2.54B |
| 2 |
Amazon
AMZN
|
+$1.38B |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$827M |
| 4 |
Public Service Enterprise Group
PEG
|
+$725M |
| 5 |
Union Pacific
UNP
|
+$721M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.49B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.03B |
| 3 |
McDonald's
MCD
|
+$1.01B |
| 4 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$871M |
| 5 |
Exelon
EXC
|
+$709M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.28% |
| 2 | Healthcare | 12.84% |
| 3 | Financials | 10.61% |
| 4 | Consumer Discretionary | 7.72% |
| 5 | Industrials | 7.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3001
Kyndryl
KD
$2.87B
| $3.45M | ﹤0.01% |
310,196
-173,576
| -36% | -$1.75M |
|
3002
Stock Yards Bancorp
SYBT
$2.64B
| $3.43M | ﹤0.01% |
52,777
+3,695
| +8% | +$264K |
|
3003
Seres Therapeutics
MCRB
$45.6M
| $3.43M | ﹤0.01% |
30,627
-4,892
| -14% | -$656K |
|
3004
State Street SPDR S&P Health Care Equipment ETF
XHE
$169M
| $3.42M | ﹤0.01% |
38,062
+1,172
| +3% | +$103K |
|
3005
Simplify Hedged Equity ETF
HEQT
$305M
| $3.42M | ﹤0.01% |
151,587
+141,587
| +1,416% | +$3.3M |
|
3006
Global X MLP ETF
MLPA
$2.3B
| $3.42M | ﹤0.01% |
82,801
+80,510
| +3,514% | +$3.37M |
|
3007
TG Therapeutics
TGTX
$7.46B
| $3.4M | ﹤0.01% |
287,816
-942
| -0.3% | -$6.84K |
|
|
HJEN
3008
DELISTED
Direxion Hydrogen ETF
HJEN
| $3.4M | ﹤0.01% |
250,000
| – | – |
|
3009
Endava
DAVA
$164M
| $3.39M | ﹤0.01% |
44,336
+36,976
| +502% | +$2.75M |
|
3010
CALL
BioCryst Pharmaceuticals
BCRX
$2.49B
| $3.39M | ﹤0.01% |
+295,000
| New | +$3.68M |
|
|
SEI
3011
Solaris Energy Infrastructure
SEI
$4.17B
| $3.38M | ﹤0.01% |
340,509
-16,228
| -5% | -$178K |
|
3012
The GEO Group
GEO
$4.11B
| $3.38M | ﹤0.01% |
308,357
-1,891,923
| -86% | -$18.4M |
|
3013
Fidelity MSCI Industrials Index ETF
FIDU
$2.4B
| $3.37M | ﹤0.01% |
+66,493
| New | +$3.3M |
|
3014
PUT
Warner Bros
WBD
$70.2B
| $3.37M | ﹤0.01% |
355,700
| – | – |
|
|
TRTX
3015
TPG RE Finance Trust
TRTX
$609M
| $3.37M | ﹤0.01% |
496,492
-110,005
| -18% | -$811K |
|
|
SNBR
3016
DELISTED
Sleep Number
SNBR
| $3.36M | ﹤0.01% |
129,460
+35,756
| +38% | +$1.09M |
|
3017
HNI Corp
HNI
$3.53B
| $3.36M | ﹤0.01% |
118,123
-63,667
| -35% | -$1.81M |
|
|
XRN
3018
Chiron Real Estate Inc
XRN
$491M
| $3.36M | ﹤0.01% |
70,808
-37,129
| -34% | -$1.68M |
|
3019
Transocean
RIG
$6.43B
| $3.34M | ﹤0.01% |
732,523
-37,310
| -5% | -$144K |
|
3020
CALL
Illumina
ILMN
$28.8B
| $3.34M | ﹤0.01% |
16,962
+7,607
| +81% | +$1.58M |
|
3021
MP Materials
MP
$10.5B
| $3.33M | ﹤0.01% |
137,190
-34,075
| -20% | -$1.03M |
|
3022
Amalgamated Financial
AMAL
$1.53B
| $3.33M | ﹤0.01% |
144,447
-104,513
| -42% | -$2.53M |
|
3023
iShares US Equity Factor ETF
LRGF
$3.74B
| $3.32M | ﹤0.01% |
+85,209
| New | +$3.33M |
|
3024
Orthofix Medical
OFIX
$421M
| $3.32M | ﹤0.01% |
161,833
-4,853
| -3% | -$85.6K |
|
3025
CALL
Lam Research
LRCX
$416B
| $3.32M | ﹤0.01% |
79,000
+10,000
| +14% | +$418K |
|
Similar funds
JP Morgan Chase's Q4 2022 Portfolio in Review
As of Q4 2022, JP Morgan Chase held 7,423 positions worth $759B, up 8.9% from $696B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q4 2022 filing shows 754 new, 2,940 increased, 2,285 reduced and 594 closed positions. Its largest new stake was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M. The largest sale was Invesco QQQ Trust, an estimated $1.49B.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Healthcare and Financials.
- JP Morgan Chase's largest Q4 2022 buy was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M.
- JP Morgan Chase added most to Vanguard Tax-Exempt Bond Index Fund in Q4 2022, an estimated $2.54B increase.
- JP Morgan Chase's biggest Q4 2022 reduction was Invesco QQQ Trust, cutting an estimated $1.49B.
- JP Morgan Chase fully exited Duke Realty Corp. in Q4 2022, selling an estimated $424M.
- JP Morgan Chase's ten largest holdings make up 16% of its $759B portfolio in Q4 2022.
- JP Morgan Chase opened 754 new positions and closed 594 in Q4 2022.
- JP Morgan Chase's portfolio value rose 8.9% quarter-over-quarter to $759B.
Based on JP Morgan Chase's 13F filing for Q4 2022, filed 13 Feb 2023.